Early bronchoconstriction and late eosinophilic inflammation in one composite adult with occupational cat allergy are matched, phase by phase, to inhaled agents in this NU559 respiratory case study. Searches like "nu 559 unit 4 assignment example", "nu559 unit 4 sample" and "nu559 unit 4 example" land here.
Two Clocks in One Airway: The Early and Late Asthmatic Responses of a Veterinary Technician, Each Matched to Its Inhaler
[Student Name]
Purdue University Global
NU559: Essentials of Advanced Pathophysiology and Pharmacology
Unit 4 Respiratory Case Study
[Instructor Name]
[Date]
The patient is a composite; values in brackets are illustrative.
Presentation
Ms. [D.], 31, has worked for four years as a technician in a small-animal clinic. She has had asthma since childhood, mild and rarely troublesome until the last year. Her symptoms now follow a pattern she can describe precisely. Within ten minutes of restraining a cat for an examination, she wheezes and feels her chest tighten; her rescue inhaler relieves it within minutes. Then, in the evening, five to eight hours after the exposure, her chest tightens again, and she coughs into the night.
She uses her [albuterol] inhaler on [five] days of every [seven] and wakes with symptoms [twice] a month. She takes no controller medicine. Spirometry shows an FEV1 of [74] percent of predicted, rising by [15] percent after a bronchodilator, confirming reversible airflow obstruction.
Mechanism, Part 1: The Minutes Clock
Ms. [D.] is sensitized to cat allergen, chiefly the protein Fel d 1, carried on dander and saliva. In a sensitized person, allergen-specific IgE antibodies sit bound to receptors on mast cells lining the airway. When she inhales the allergen, it cross-links adjacent IgE molecules on the mast cell surface, triggering degranulation within seconds (Busse & Lemanske, 2001).
The mast cell releases preformed histamine and rapidly synthesizes cysteinyl leukotrienes and prostaglandin D2. These mediators contract airway smooth muscle, increase vascular permeability and stimulate mucus secretion. The airway narrows within minutes. This early asthmatic response peaks at about 15 to 30 minutes and usually resolves within one to two hours.
Mechanism, Part 2: The Hours Clock
The mast cell's work does not end with the early response. It and other cells in the airway release cytokines that set up a second wave. Th2 lymphocytes, activated by the allergen presented to them, produce interleukin-4, which sustains IgE production; interleukin-5, which recruits and activates eosinophils; and interleukin-13, which increases mucus production and airway hyperresponsiveness (Busse & Lemanske, 2001).
Over the following three to eight hours, eosinophils, basophils and more lymphocytes migrate into the airway wall. Eosinophils release toxic granule proteins and more leukotrienes, damaging the epithelium and making the airway swollen and twitchy. The late asthmatic response is not a second contraction of the same muscle but a different process: inflammation arriving in tissue that the allergen left hours earlier. It explains her evening chest tightness and night cough, and repeated late responses keep the airway hyperresponsive, so she reacts more easily the next day.
Therapy, Part 1: The Minutes Clock
Short-acting beta-2 agonists, such as [albuterol], act on the beta-2 receptors that stud the muscle of the bronchial wall. The receptor activates adenylyl cyclase, raising cyclic AMP, which activates protein kinase A and relaxes the muscle. The effect begins within minutes, which is why her inhaler relieves the early response quickly.
The same mechanism explains the limit. A beta-2 agonist relaxes muscle but does nothing to the eosinophils, cytokines or edema of the late response. Relief of the evening symptoms is temporary, because the inflammation continues underneath. Frequent use of a reliever alone, as in her case, is associated with worse outcomes, and asthma guidance no longer recommends short-acting beta-2 agonist treatment without an inhaled corticosteroid.
Therapy, Part 2: The Hours Clock
Inhaled corticosteroids, such as [budesonide], act inside cells. The steroid binds the glucocorticoid receptor in the cytoplasm, and the complex moves into the nucleus, where it switches off the transcription of many inflammatory genes, including those for Th2 cytokines, and switches on anti-inflammatory genes (Barnes, 2006). The result, over days to weeks, is fewer eosinophils and mast cells in the airway, less edema and less hyperresponsiveness.
That is why regular use matters more than the timing of any single dose. A corticosteroid taken after the late response has begun will not stop it that evening. Taken consistently, it reduces the inflammation that produces late responses and makes the airway less reactive to the next exposure. Given before an expected exposure, an inhaled corticosteroid can blunt the late response.
A combination of an inhaled corticosteroid with formoterol, a long-acting beta-2 agonist with a rapid onset, used as both maintenance and reliever, puts both clocks in one inhaler. In mild asthma, budesonide-formoterol taken as needed controlled symptoms and reduced exacerbations far better than a short-acting reliever alone (O'Byrne et al., 2018).
Other Agents on the Map
Leukotriene receptor antagonists, such as [montelukast], block the cysteinyl leukotriene receptor. They act on both clocks, since leukotrienes contribute to the early contraction and the late inflammation, but they are less effective than an inhaled corticosteroid and carry a warning about neuropsychiatric effects. Long-acting muscarinic antagonists, such as [tiotropium], block acetylcholine at airway smooth muscle and are added in more severe asthma. Neither is her first step.
Monitoring the Change
The two clocks also shape how the new regimen is judged. Relief of the minutes clock is visible at once, but control of the hours clock takes weeks to appear, so she is reviewed four to six weeks after starting the corticosteroid, not sooner. The review asks how many days she needed a reliever, whether evening chest tightness and night waking have eased, and whether her FEV1 has risen. Her inhaler technique is watched, since poor technique is one of the commonest reasons a controller seems to fail.
A peak flow diary adds evidence on both questions. Readings taken several times a day on work days and on days off would show whether her airflow falls during shifts and recovers away from the clinic, which supports a work-related diagnosis, and whether the corticosteroid is narrowing the evening dips that mark her late responses.
Discussion: What No Inhaler Reaches
Her regimen, a reliever alone, treats the minutes clock and leaves the hours clock untouched. Starting an inhaled corticosteroid, most simply as budesonide-formoterol for maintenance and relief, addresses both.
But the upstream step, the allergen reaching her airway, is her workplace. Her asthma worsened after she began this job, and her symptoms follow exposures there. That pattern suggests work-exacerbated or occupational asthma, which calls for an assessment of exposure, workplace controls and, in some cases, specialist referral (Tarlo & Lemiere, 2014). Gloves, a fitted mask when handling cats, improved ventilation and task changes may reduce exposure. The referral question is bracketed for the team: [referral to occupational medicine or allergy for assessment of work-related asthma].
References
Barnes, P. J. (2006). How corticosteroids control inflammation: Quintiles Prize Lecture 2005. British Journal of Pharmacology, 148(3), 245-254. https://doi.org/10.1038/sj.bjp.0706736
Busse, W. W., & Lemanske, R. F. (2001). Asthma. New England Journal of Medicine, 344(5), 350-362. https://doi.org/10.1056/NEJM200102013440507
O'Byrne, P. M., FitzGerald, J. M., Bateman, E. D., Barnes, P. J., Zhong, N., Keen, C., Jorup, C., Lamarca, R., Ivanov, S., & Reddel, H. K. (2018). Inhaled combined budesonide-formoterol as needed in mild asthma. New England Journal of Medicine, 378(20), 1865-1876. https://doi.org/10.1056/NEJMoa1715274
Tarlo, S. M., & Lemiere, C. (2014). Occupational asthma. New England Journal of Medicine, 370(7), 640-649. https://doi.org/10.1056/NEJMra1301758
How this NU559 Unit 4 example is structured
Timing organizes the whole case. Every finding is placed on one of two clocks, minutes or hours, and every drug is placed on the clock it can affect. That arrangement is what turns a list of asthma drugs into an argument. The beta-2 agonist section follows the receptor to cyclic AMP and smooth muscle relaxation, which accounts for both its speed and its inability to reduce inflammation. The corticosteroid section explains gene transcription effects that reduce eosinophils, mast cells and airway hyperresponsiveness over days rather than minutes, which is why regular use matters more than the timing of any single dose. A shorter paragraph places a leukotriene receptor antagonist and a long-acting muscarinic antagonist on the map for completeness. The discussion closes on her workplace, where allergen exposure is the upstream step no inhaler reaches, bracketed as a referral question.
Get an NU559 Unit 4 example written to your instructions
Asthma, COPD or a mixed picture all suit this format. Forward the NU559 Unit 4 case with any spirometry it supplies plus its rubric, and the sample, patient composite and agents bracketed, returns in 24-48h with each airway process matched to the drug acting on it. Nothing is charged for a first one. The paper above is an original model document written by our desk, not a submitted student paper and not an official Purdue University Global document.
NU559 Unit 4 questions, answered
Should the case study cover biologic therapies?
Only if the prompt or the severity of the case calls for them. Anti-IgE and anti-IL-5 agents fit neatly on the same mechanism map, and a sentence placing them can show range. For a patient with moderate symptoms on a reliever alone, however, a long section on biologics suggests the paper has drifted away from the person the case describes.
How much spirometry interpretation is expected?
Enough to connect the numbers to the mechanism. A reduced FEV1 that improves meaningfully after a bronchodilator supports reversible smooth muscle constriction, which is the first process the paper describes. Stating the values without saying what they indicate is a common gap; a sentence or two linking reversibility to the early phase usually satisfies this part of the rubric.
Can a real patient from work supply the case details?
It is safer not to, even with names removed, because an occupation combined with a trigger can point to one person. Composite patients assembled from typical features give the same teaching value. The sample uses a composite throughout and brackets every value, and a student paper can do the same while still meeting a rubric's demand for realistic detail.